Hanseul Kim

Hanseul Kim

Auto-generated profile, based on publicly available information

Hanseul Kim

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
HKHanseul Kim
Hanseul Kim
MLMarla Lipsyc-Sharf
Marla Lipsyc-Sharf
XZXiaoyu Zong
Xiaoyu Zong
XWXiaoyan Wang
Xiaoyan Wang
JHJinhee Hur
Jinhee Hur
EGEdward Giovannucci
Edward Giovannucci

31 October 2022 in International Journal of Epidemiology
Verified
Journal Article
Closed access
PDF file
HKHanseul Kim
Hanseul Kim
JHJinhee Hur
Jinhee Hur
KWKana Wu
Kana Wu
MSMingyang Song
Mingyang Song
MWMolin Wang
Molin Wang
EGEdward Giovannucci
Edward Giovannucci
Although colorectal cancer (CRC) incidence is declining among adults aged ≥65 years, CRC incidence in younger adults has been rising. The protective role of calcium in colorectal carcinogenesis has been well established, but evidence is lacking on whether the association varies by age at diagnosis. We investigated the association between total calcium intake and risk of overall CRC and CRC before age 55 years. In the Nurses’ Health Study II (1991–2015), 94 205 women aged 25–42 years at baseline were included in the analysis. Diet was assessed every 4 years through validated food frequency questionnaires. Multivariable-adjusted hazard ratios (HRs) and 95% CIs for CRC were estimated using the Cox proportional hazards model. We documented 349 incident CRC cases during 2 202 604 person-years of follow-up. Higher total calcium intake was associated with a reduced risk of CRC. Compared with those with <750 mg/day of total calcium intake, the HR of CRC was 0.61 (95% CI, 0.38–0.97) for those who consumed ≥1500 mg/day (P for trend = 0.01). The HR per 300 mg/day increase was 0.85 (95% CI, 0.76–0.95). There was a suggestive inverse association between total calcium intake and CRC before age 55 years (HR per 300 mg/day increase, 0.87; 95% CI, 0.75–1.00), suggesting the importance of calcium intake in the younger population. In a cohort of younger women, which reflects the birth cohorts, time periods and age ranges paralleling the recent rise in CRC, higher calcium intake was associated with a decreased risk of CRC.

6 April 2018 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
HKHanseul Kim
Hanseul Kim
NKNaNa Keum
NaNa Keum
EGEdward L. Giovannucci
Edward L. Giovannucci
CFCharles S. Fuchs
Charles S. Fuchs
YBYing Bao
Ying Bao

11 February 2021 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
HKHanseul Kim
Hanseul Kim
KWKai Wang
Kai Wang
MSMingyang Song
Mingyang Song
EGEdward Giovannucci
Edward Giovannucci

23 December 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
HKHanseul Kim
Hanseul Kim
CYChen Yuan
Chen Yuan
LNLong H Nguyen
Long H Nguyen
KNKimmie Ng
Kimmie Ng
EGEdward Giovannucci
Edward Giovannucci
Context Lower 25-hydroxyvitamin D (25(OH)D) levels have consistently been associated with higher mortality among participants with colorectal cancer (CRC). Objective To investigate whether the association between 25(OH)D and CRC mortality differs according to vitamin D binding protein (also known as Gc) isoforms. Methods We examined the association between prediagnostic 25(OH)D levels and overall and CRC-specific mortality among participants with CRC within 2 prospective US cohorts. Cox proportional hazards regression was used to estimate the hazard ratios (HRs) and 95% CIs. Results 588 participants with CRC were observed until the date of death or last follow-up (2018), whichever came first. Deficient vs sufficient 25(OH)D concentrations (<30 vs ≥50 nmol/L) were associated with higher overall mortality (HR 2.06; 95% CI 1.34-3.18) but not with CRC-specific mortality (HR 1.51; 95% CI 0.75-3.07). The HRs for overall mortality comparing deficient vs sufficient concentrations were 2.43 (95% CI 1.26-4.70) for those with the Gc1-1 isoform (rs4588 CC) and 1.63 (95% CI 0.88-3.02) for those with the Gc1-2 or Gc2-2 (rs4588 CA or AA) isoform (P for interaction = .54). The HRs for CRC-specific mortality were 1.18 (95% CI 0.27-5.14) for those with the Gc1-1 isoform and 1.41 (95% CI 0.62-3.24) for those with the Gc1-2 or Gc2-2 isoform (P for interaction = .94). Conclusion In these 2 US cohorts, we found that lower 25(OH)D levels were associated with higher overall mortality, but this association did not differ by Gc isoforms.

29 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SCSheng-Yin Chen
Sheng-Yin Chen
HKHanseul Kim
Hanseul Kim
EEEtienne Etienne
Etienne Etienne
JSJiaxian Shen
Jiaxian Shen
KWKatherine Williams
Katherine Williams
HKHamed Khalili
Hamed Khalili
Background: Microscopic colitis (MC) is a common cause of chronic diarrhea, predominantly among older adults. Emerging evidence suggests that perturbations of gut microbiome and metabolome may play an important role in MC pathogenesis. Objective: To comprehensively characterize alterations of the gut microbial and metabolic composition in MC. Design: We established a longitudinal cohort of adult patients with MC and two control groups of individuals – chronic diarrhea controls and age- and sex-matched controls without diarrhea. Using stool samples, gut microbiome was analyzed by whole-genome shotgun metagenomic sequencing, and gut metabolome was profiled by ultra-high performance liquid chromatography–mass spectrometry. Per-feature enrichment analyses of microbial species, metabolic pathways, and metabolites were done using multivariable linear models both cross-sectionally comparing MC to controls and longitudinally according to disease activity. Lastly, we performed multi-omics association analyses to assess the relationship between microbiome and metabolome data. Results: We included 683 participants, 131 with active MC (66 with both active and remission samples), 159 with chronic diarrhea, and 393 age- and sex-matched controls without diarrhea. The stool microbiome in active MC was characterized by a lower alpha diversity as compared to controls and the remission phase of MC. Compared to controls, we identified eight enriched species in MC, most of which were pro-inflammatory oral-typical species, such as Veillonella dispar and Haemophilus parainfluenzae . In contrast, 11 species, including anti-inflammatory microbes such as Blautia glucerasea and Bacteroides stercoris, were depleted in MC. Similarly, pro-inflammatory metabolites, including lactosylceramides, ceramides, lysophospholipids, and lysoplasmalogens were enriched in active MC as compared to controls or MC cases in remission. Multi-omics association analyses revealed strong and concordant links between microbes, their metabolic pathways, and metabolomic profiles, supporting the tight interplay between disturbances in stool microbiome and metabolome in MC. Conclusion: We observed a significant shift in stool microbial and metabolomic composition in MC. Our findings could be used in the future for development of non-invasive biomarkers for diagnosing and monitoring MC and developing novel therapeutics. What is already known on this topic: Microbiome dysbiosis has been proposed to contribute to microscopic colitis (MC) pathogenesis. However, previous studies have been limited by small sample sizes, reliance on 16S rRNA sequencing technique, potential confounding by stool consistency, and lack of functional analyses of microbiome and longitudinal data. Moreover, the metabolomic composition of MC remain largely unknown. What this study adds: In this largest longitudinal MC cohort with two control groups – chronic diarrhea controls and controls without diarrhea, gut microbiome of MC is characterized by a lower alpha diversity, enriched pro-inflammatory oral-typical species and depleted anti-inflammatory beneficial species. Gut metabolome of MC shows significant enrichment of pro-inflammatory metabolites, including lactosylceramides, ceramides, lysophospholipids, and lysoplasmalogens. Multi-omics analyses demonstrate strong and concordant relationships between microbes, metabolic pathways, and metabolomic profiles. How this study might affect research, practice or policy: Our findings could facilitate development of non-invasive biomarkers and novel therapeutics for MC.